Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

NCT02174094 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was terminated due to recruitment challenges

Conditions

Dravet Syndrome

Interventions

DRUG: Clobazam
DRUG: Placebo

Sponsor

H. Lundbeck A/S